Saudi Pharmaceutical Industries and Medical Appliances Corporation (SASE:2070) agreed to acquire 68% stake in Osmopharm SA for SAR 16.1 million on November 14, 2023. The transaction s expected to be completed in the first half of 2024, contingent on regulatory approvals. Olha Demianiuk and Dr. Alexander Wyss of Baker & McKenzie acted as legal advisor to Saudi Pharmaceutical Industries and Medical Appliances Corporation.
Saudi Pharmaceutical Industries and Medical Appliances Corporation
Equities
2070
SA0007879188
Pharmaceuticals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.6 SAR | -2.89% | -3.05% | -24.34% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-24.34% | 918M | |
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |
- Stock Market
- Equities
- 2070 Stock
- News Saudi Pharmaceutical Industries and Medical Appliances Corporation
- Saudi Pharmaceutical Industries and Medical Appliances Corporation agreed to acquire 68% stake in Osmopharm SA for SAR 16.1million.